Case report: Intra-abdominal aggressive fibromatosis: A rare cause of hyperemesis.

APC aggressive fibromatosis (AF) case report desmoid-type fibromatosis hyperemesis

Journal

Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127

Informations de publication

Date de publication:
2023
Historique:
received: 25 11 2022
accepted: 06 02 2023
entrez: 10 3 2023
pubmed: 11 3 2023
medline: 11 3 2023
Statut: epublish

Résumé

Aggressive fibromatosis is a rare and locally infiltrative monoclonal fibroblastic proliferation with lack of metastatic potential. We describe a rare case of intra-abdominal aggressive fibromatosis on young female with hyperemesis. A 23-year-old female was admitted with hyperemesis and loss of weight. According to imaging findings and immunohistology findings, a diagnosis of intra-abdominal aggressive fibromatosis was formulated. After the surgery, no evidence of local recurrence was noted during the 6 months of follow-up. AF may explain why pregnant women may have severe hyperemesis.

Identifiants

pubmed: 36896261
doi: 10.3389/fsurg.2023.1108225
pmc: PMC9989300
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1108225

Informations de copyright

© 2023 Zou, Ye, Xu, Liu and Wang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Pathology. 2014 Feb;46(2):95-104
pubmed: 24378391
Cancer Med. 2022 May;11(10):2079-2084
pubmed: 35274811
Cancer Rep (Hoboken). 2021 Dec;4(6):e1411
pubmed: 34165246
Mol Cell Ther. 2015 Jan 30;3:1
pubmed: 26056602
Cancer Treat Res Commun. 2022;31:100562
pubmed: 35460976
World J Clin Oncol. 2019 Apr 24;10(4):183-191
pubmed: 31114750
PLoS One. 2021 Apr 29;16(4):e0250619
pubmed: 33914771
J Surg Oncol. 2017 Nov;116(6):716-721
pubmed: 28570749
Surg Neurol Int. 2022 Feb 18;13:64
pubmed: 35242430
Eur J Cancer. 2020 Mar;127:96-107
pubmed: 32004793
Ann Surg Oncol. 2015 Sep;22(9):2817-23
pubmed: 26045393

Auteurs

Zilin Zou (Z)

The Affiliated Changsha Hospital, Hengyang Medical School, University of South China, Changsha, China.

Guannan Ye (G)

Department of Gastroenterology, The First Hospital of Changsha, Changsha, China.

Saiqun Xu (S)

Department of Gastroenterology, The First Hospital of Changsha, Changsha, China.

Wei Liu (W)

Department of Gastroenterology, The First Hospital of Changsha, Changsha, China.

Weining Wang (W)

Department of Gastroenterology, The First Hospital of Changsha, Changsha, China.

Classifications MeSH